Clinical trial
Phase II trial evaluating combined image guided radiotherapy with Panitumumab (Vectibix�) in patients with muscle invasive transitional cell carcinoma of the bladder
Primary objective is to evaluate the safety of combined radiotherapy with Panitumumab in bladder preservation in invasive bladder cancer.
| Category | Value |
|---|---|
| Study start date | 2010-05-12 |